Table II.
EZH2 expression | ||||
---|---|---|---|---|
Variable | No. of cases | High | Low | P-value |
Sex | ||||
Male | 54 | 40 | 14 | NS |
Female | 41 | 26 | 15 | |
Age, years | ||||
≥50 | 49 | 34 | 15 | NS |
<50 | 46 | 32 | 12 | |
Tumor size, cm | ||||
≥5 | 63 | 48 | 15 | 0.046 |
<5 | 32 | 18 | 14 | |
Lymph node metastasis | ||||
Absent | 53 | 42 | 11 | 0.041 |
Present | 42 | 24 | 18 | |
Histological differentiation | ||||
Well/moderate | 44 | 26 | 18 | 0.041 |
Poor | 51 | 40 | 11 | |
Tumor stage | ||||
I–II | 59 | 46 | 13 | 0.021 |
III–IV | 36 | 20 | 16 |
NS, not significant; EZH2, enhancer of zeste homolog 2.